# reload+after+2024-01-23 00:44:34.594060
address1§Kiryat Hadassah Minrav Building
address2§Fifth Floor
city§Jerusalem
zip§9112002
country§Israel
phone§972 2 532 7151
website§https://www.enterabio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
fullTimeEmployees§19
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Miranda J. Toledano M.B.A.', 'age': 46, 'title': 'CEO & Director', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 412500, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Hillel  Galitzer M.B.A., Ph.D.', 'age': 45, 'title': 'Chief Operating Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 387000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Dana  Yaacov-Garbeli CPA', 'age': 40, 'title': 'Chief Financial Officer', 'yearBorn': 1983, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Arthur C. Santora II, M.D., Ph.D.', 'age': 72, 'title': 'Chief Medical Officer', 'yearBorn': 1951, 'fiscalYear': 2022, 'totalPay': 355000, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.623
priceToSalesTrailing12Months§1774.6224
currency§USD
dateShortInterest§1702598400
forwardEps§-0.75
exchange§NCM
quoteType§EQUITY
shortName§Entera Bio Ltd.
longName§Entera Bio Ltd.
firstTradeDateEpochUtc§1530192600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§dd427383-c806-3358-ad72-316161860c8a
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§10.0
targetMeanPrice§10.0
targetMedianPrice§10.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§3.742
grossMargins§0.42856997
ebitdaMargins§0.0
trailingPegRatio§None
